Oncology Diagnostics Panel Session
In Part 2 of our Oncology Diagnostics series, our panelist provide some ideas on how to monetize technologies in efforts to help pay for rising development costs.
- Shailesh Maingi – Founder and CEO, Kineticos
- Eric Mayer – CEO, EDP Biotech
- Sandra Dunn – CEO, Phoenix Molecular
- Brian Kelly – Global Director, Diagnostic Partnering, Thermo Fisher
Subscribe to Kineticos to receive weekly emails containing insightful content.